U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...
Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...
Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better known under the trade names Ozempic and Wegovy, is remarkable, but it's not ...
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal ...
Some people may be eligible for Medicare coverage for Wegovy if they meet medical criteria for heart disease risk. However, Medicare does not cover medications that are strictly for weight management.